Alpha Cognition Inc.'s ability to collect accounts receivable sequentially worsen to 3.3, pointing to a challenging and on top of that deteriorating business climate for the Biotechnology & Pharmaceuticals industry. Alpha Cognition's Accounts Receivable average collection period in the Mar 31 2026 quarter, has increased to 111 days, from 89 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector Alpha Cognition Inc. achieved the highest receivable turnover ratio. While receivables turnover ratio total ranking has improved thus far to 3131, from overall ranking in the fourth quarter 2025 at 3337.

What is Receivable Turnover Ratio?
What is Alpha Cognition Inc. Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ACOG Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Receivable Change	516.61 %	1651.62 %	11895.56 %	3879.63 %	508.5 %
Y / Y Revenue Change	20.66 %	-	-	-	-
Receivable Turnover Ratio (TTM)	3.3	4.1	5.13	6.46	12.52
ACOG's Total Ranking	# 3131	# 3337	#	#	#
Accounts Receivable average collection period days	111	89	71	57	29
Seq. Receivable Change	-15.47 %	49.2 %	52.25 %	221.12 %	140.13 %
Seq. Revenue Change	26.52 %	-1.69 %	71.38 %	-43.4 %	-

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 0
Healthcare Sector	# 0
Overall Market	# 3131

Receivable Turnover Ratio Statistics
High	Average	Low
4.1	3.7	3.3
(Dec 31 2025)		(Mar 31 2026)

ACOG Company Profile • Back to ACOG Efficiency Comparisons • Compare ACOG Receivables Turnover Ratio to its Competitors

Financial Statements
Alpha Cognition's Accounts Receivable	$ 4 Millions	Visit ACOG's Balance sheet
Alpha Cognition's Sales TTM	$ 11 Millions	Visit ACOG's Income Statement
Sources of ACOG's Revenues		Visit ACOG's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ACOG's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ACOG's Growth Rates	ACOG's Roa	ACOG's Inventory Turnover Ratio	ACOG's Dividend Comparisons
ACOG's Profitability Ratios	ACOG's Roi	ACOG's Asset Turnover Ratio	ACOG's Dividend Growth
ACOG's Valuation Ratios	ACOG's Roe	ACOG's Financial Strength Ratios	ACOG's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2026	Receivable at quarter ending Mar 31 2026
Henry Schein Inc	7.92	$ 13,384.000 Millions	$ 1,689.500 Millions
Sight Sciences Inc	7.91	$ 78.550 Millions	$ 9.925 Millions
Aveanna Healthcare Holdings Inc	7.91	$ 2,521.890 Millions	$ 318.786 Millions
Trisalus Life Sciences Inc	7.91	$ 44.183 Millions	$ 5.586 Millions
Beta Bionics Inc	7.89	$ 110.003 Millions	$ 13.950 Millions
Acadia Pharmaceuticals Inc	7.88	$ 1,095.250 Millions	$ 138.935 Millions
Zymeworks Inc	7.87	$ 81.263 Millions	$ 10.324 Millions
Neuronetics Inc	7.82	$ 150.724 Millions	$ 19.272 Millions
Exelixis Inc	7.80	$ 2,375.491 Millions	$ 304.486 Millions
Idexx Laboratories Inc	7.79	$ 4,445.939 Millions	$ 570.842 Millions
Inspire Medical Systems inc	7.78	$ 915.060 Millions	$ 117.614 Millions
Myomo Inc	7.75	$ 41.180 Millions	$ 5.317 Millions
Pacs Group Inc	7.71	$ 5,432.276 Millions	$ 704.948 Millions
Acadia Healthcare Company Inc	7.70	$ 3,371.066 Millions	$ 437.934 Millions
Plus Therapeutics Inc	7.70	$ 5.182 Millions	$ 0.673 Millions
Quest Diagnostics Inc	7.69	$ 11,278.000 Millions	$ 1,467.500 Millions
Uniqure N v	7.68	$ 18.093 Millions	$ 2.356 Millions
Natera Inc	7.64	$ 2,500.927 Millions	$ 327.432 Millions
Cannapharmarx Inc	7.57	$ 1.654 Millions	$ 0.219 Millions
Foxo Technologies Inc	7.56	$ 27.325 Millions	$ 3.615 Millions
Omada Health Inc	7.55	$ 281.916 Millions	$ 37.326 Millions
Tela Bio Inc	7.55	$ 80.349 Millions	$ 10.643 Millions
Novocure Limited	7.54	$ 674.414 Millions	$ 89.464 Millions
Intuitive Surgical Inc	7.49	$ 10,582.100 Millions	$ 1,412.950 Millions
Cue Biopharma Inc	7.48	$ 32.731 Millions	$ 4.378 Millions
Maravai Lifesciences Holdings Inc	7.46	$ 203.841 Millions	$ 27.333 Millions
Travere Therapeutics Inc	7.42	$ 536.195 Millions	$ 72.285 Millions
Lemaitre Vascular Inc	7.42	$ 256.515 Millions	$ 34.583 Millions
Twist Bioscience Corporation	7.41	$ 409.479 Millions	$ 55.272 Millions
Quidelortho Corp	7.39	$ 2,657.200 Millions	$ 359.600 Millions

Date modified: 2026-08-29T18:40:12+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.